Letter

Seroprotection and meningitis C

Meningococcal C booster not recommended by evidence

BMJ 2008; 337 doi: 10.1136/bmj.a1139 (Published 11 August 2008)
Cite this as: BMJ 2008;337:a1139

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. H Lucy Thomas, specialist registrar in public health1,
  2. Nick Andrews1,
  3. Caroline Trotter1,
  4. Mary Ramsay1,
  5. Elizabeth Miller1
  1. 1Health Protection Agency Centre for Infection, London NW9 5EQ
  1. lucy.thomas{at}hpa.org.uk

    Snape et al recommend that a booster dose of meningococcal group C glycoconjugate vaccine (MenC) be administered to children entering adolescence in the UK in the next five years.1 However, their study did not look for, or provide, any evidence of increasing nasopharyngeal carriage in pre-adolescents, and underestimates the protective effect of herd …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular